Australia News All stories

IperionX (ASX:IPX) has received the final US$4.6 million of a previously awarded US$47.1 million from the US Department of War.

Lunnon Metals (ASX:LM8) has completed a feasibility study on its Lady Herial gold deposit, part of the Kambalda Gold & Nickel Project.

Evolution Energy Minerals (ASX:EV) has recommenced soil sampling at its Chikundo Copper Project, located within the company's highly prospective Chilalo tenure in southern Tanzania.

Australia welcomed 1.85 million international arrivals in November 2025, marking an 8.4% increase compared with the same month in 2024.

Forrestania Resources (ASX:FRS) has moved to strengthen its Coolgardie Hub in Western Australia by entering a binding heads of agreement to acquire rights, title, and interests in tenements from Christopher Alan De Courcy Ryder and Lloyd George Holdings (Gibraltar).

Qube Holdings (ASX:QUB) has confirmed that Macquarie Asset Management has met the conditions outlined in their November 2025 exclusivity agreement.

Sonic Healthcare's (ASX:SHL) new CEO, Jim Newcombe, is facing investor pressure to reconsider the company’s US operations as he steps into the shoes of long-serving predecessor Colin Goldschmidt.

Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX), a global leader in 3D-printed biomimetic and bioresorbable implants, has entered a multi-year exclusive agreement with Majeton to commercialise its dental, orthodontic, and maxillofacial products across China, Hong Kong, and Macau.

Copper producer Austral Resources Australia (ASX:AR1) has struck a major deal to acquire the Lady Loretta mining leases, associated exploration permits, and site infrastructure from Glencore AG.

Department store giant Myer (ASX:MYR) will temporarily close all Sass & Bide stores, including its Claremont location, s part of a major revamp of the high-profile womenswear label.

CBH has confirmed it has not yet finalised a deal with US agribusiness giant Cargill to back a $500 million canola refinery in East Rockingham, amid speculation an agreement is imminent.

Wellnex Life (ASX:WNX) has reported a significant turnaround in its financial performance for the six months ended Dec. 31, 2025, with H1 FY26 EBITDA rising $2.4 million.

SRJ Technologies Group (ASX:SRJ) announced that its wholly-owned UAE subsidiary, First Avenue General Contracting – Sole Proprietorship, has secured a US$879,000 purchase order with CAPSA Engineering & Contracting.

Proteomics International Laboratories (ASX: PIQ) has secured Canadian patent protection for PromarkerEso, its first-in-class blood test for the early detection of esophageal adenocarcinoma.

Nearly five million social media accounts belonging to Australian teenagers have been deactivated just a month after the country implemented a world-first ban on under-16s.

James Hardie Industries (ASX:JHX) announced plans to optimise its manufacturing footprint by closing its facilities in Fontana, California.

Rio Tinto (ASX:RIO) and Glencore are reportedly weighing a potential spin-off of selected assets, including coal, on the ASX as part of early-stage discussions around a mooted $300 billion mega-merger.

Ora Banda Mining (ASX:OBM) has reported significant high-grade drill results at its Waihi Project, with targeted follow-up drilling on the Golden Pole Lode continuing to expand the mineralised envelope.

Terra Metals’ (ASX:TM1) initial assays from the SW5 target at the Southwest prospect within the Dante Project have confirmed a second new platinum group metal–copper–nickel sulfide discovery.

Marquee Resources (ASX:MQR) has reported high-grade gold results from its Mt Clement Project in Western Australia.

The Finance Sector Union has sharply criticised People First Bank’s plan to close 15 more branches across New South Wales, Queensland, Victoria.

High-Tech Metals (ASX: HTM) has resumed reverse circulation drilling at its high-grade Wagtail gold deposit in Western Australia.

Terrain Minerals (ASX:TMX) has recommenced its reverse circulation drilling campaign at the 100% owned Smokebush Gold & Silver Project.

Clarity Pharmaceuticals (ASX:CU6) has announced that the SECuRE trial, a Phase 1/2a study of 67Cu-SAR-bisPSMA for metastatic castration-resistant prostate cancer.